CFX News and Press, Colfax Corporation From 08/20/20

The EMPOWR Acetabular™ System and EMPOWR Partial Knee™ restore healthy kinematics and promote surgical efficiency with single-tray implantation DJO, LLC (“DJO” or the “Company”), a leading global provider of medical technologies to get and kee...

Colfax Corporation (CFX) Q2 2020 Earnings Conference Call August 6, 2020 8:00 AM ET Company Participants Mike Macek – Vice President-Finance Matt Trerotola – President and Chief Executive Officer Chris Hix – Executive Vice President and Chief Financial Office...

The following slide deck was published by Colfax Corporation in conjunction with their 2020 Q2 earnings Read more ...

A digital patient relationship management tool that seamlessly connects clinicians and patients across the orthopedic care continuum DJO, LLC (“DJO” or the “Company”), a leading global provider of medical technologies to get and keep people moving, introduce...

Image source: The Motley Fool. Colfax Corp   (NYSE: CFX) Q2 2020 Earnings Call Aug 6, 2020 , 8:00 a.m. ET Operator Continue reading

Colfax (NYSE: CFX ) : Q2 Non-GAAP EPS of $0.09 beats by $0.03 ; GAAP EPS of -$0.03 beats by $0.12 . More news on: Colfax Corporation, Earnings news and commentary, Read more ...

•         Achieved objectives to address COVID-19 impacts, including generating positive cash flow •         Reported $(0.03) EPS from continuing operations and achieved $0.09 of adjusted EPS • &...

Industrial stocks have done pretty well over the last three months on what I’m tempted to call “the Bob Marley trade” (“… cause every little thing gonna be alright…”), and in many cases, I think the rebounds in share prices have outpaced the lik...

Annapolis Junction, MD, July 14, 2020 (GLOBE NEWSWIRE) -- Colfax Corporation (NYSE: CFX), a leading diversified technology company, today announced that it will issue a press release providing financial results for the second quarter of 2020 on the morning of Thursday, August 6, 2020. The C...

This article is part of a series that provides an ongoing analysis of the changes made to Wallace Weitz’s 13F portfolio on a quarterly basis. It is based on Weitz’s regulatory 13F Form filed on 05/11/2020. Please visit our Tracking Wallace Weitz’s Weitz Investment Manag...